LYELLyell Immunopharma, Inc.vs its industry peers
A metric-by-metric comparison of Lyell Immunopharma, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LYELEsta | $275M#1 | — | 1.2x#3 | 7644.2x#5 | -41.0%#4 | 20.0%#2 | -748344.4%#6 | -117.4%#5 | — | — | — | — |
| RCKT | $264M#2 | — | 0.7x#2 | — | — | 13.8%#3 | — | -60.5%#4 | — | — | — | — |
| BIOA | $260M#3 | — | 0.7x#1 | 28.9x#3 | — | -13.4%#5 | -1031.5%#4 | -21.5%#2 | — | — | — | — |
| QTTB | $256M#4 | 2.7x#1 | 2.4x#5 | 4.8x#2 | — | 162.5%#1 | 31.5%#1 | 28.1%#1 | — | — | — | — |
| GLSI | $255M#5 | — | 81.8x#6 | — | — | -11.2%#4 | — | -621.1%#7 | — | — | — | — |
| BCYC | — | — | — | — | 105.8%#2 | -29.5%#6 | -340.4%#3 | -43.3%#3 | -372.9%#3 | — | — | — |
| CAMP | $251M#6 | — | — | 71.8x#4 | 436.5%#1 | -55.2%#7 | -1502.4%#5 | — | — | — | — | — |
| LRMR | $245M#7 | — | 1.9x#4 | — | — | -105.5%#8 | — | -130.1%#6 | -350.3%#2 | — | -39.5%#1 | — |
| LFCR | $243M#8 | — | — | 1.9x#1 | 0.5%#3 | -422.5%#9 | -13.4%#2 | — | -28.7%#1 | 3#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice